INTRODUCTION
============

Pulmonary inflammatory pseudotumor is a relatively rare benign tumor located in the lungs but could occur in the mesentry, greater omentum, liver, bladder and upper respiratory tract. Most of the patients are under 40 years of age and complain mainly of non-specific symptoms. Lesions are shown as pulmonary nodules or masses in which the border can be characteristically well distinguished on X-ray. Diagnosis of this tumor is difficult without surgical biopsy or resection. It is principally treated with surgery. This tumor was reported as fibrous histiocytoma, plasma cell granuloma and inflammatory pseudotumor in Korea. A total of 27 cases of pulmonary inflammatory pseudotumor have been reported in Korea, including 3 cases reported from Severance Hospital, until January 2001. However, most of the cases were simple case reports so that comprehensive discussion on pulmonary inflammatory pseudotumor was not enough in those series. Thus, we conducted a review of the literature on pulmonary inflammatory pseudotumor, including a case that we recently experienced, to examine the clinical features, diagnosis and treatment of this disease.

MATERIALS AND METHODS
=====================

1.. Materials
-------------

We collected 28 cases of pulmonary inflammatory pseudotumor in Korea, including 4 cases that we experienced at the Severance Hospital, and supplemented from the literature reported as fibrous histiocytoma, plasma cell granuloma and inflammatory pseudotumor since 1977.

2.. Methods
-----------

Through the review of the literature, we collected the patients' data, including age, gender, chief complaint, hematologic examination, size and location of the lesion, cavity formation, presence of calcification and treatment method. Referring to the studies already published, some items were not available for each case^[@b2-kjim-17-4-252-8],\ [@b8-kjim-17-4-252-8],\ [@b10-kjim-17-4-252-8],\ [@b12-kjim-17-4-252-8],\ [@b14-kjim-17-4-252-8])^. Information for the gender of the patient could be confirmed in 27 cases, that for the age in 20 cases, and that for the clinical pattern in 27 cases. Hematologic findings were described in 15 cases. Size of the lesion could be determined in 21 cases. Radiographic or pathologic findings were described in 27 cases. Diagnostic method could be confirmed in 28 cases and treatment method in 27 cases.

RESULTS
=======

The cases of pulmonary inflammatory pseudotumor reported in Korea are summarized in [Table 1](#t1-kjim-17-4-252-8){ref-type="table"}. Male was more prevalent than female in 22 out of 27 cases (81.5%) and the mean age was 37.9 years old (range: 6--63 yrs).

As for the clinical features, a majority of the patients, 12 cases (44.4%) out of 27 cases, complained of cough, followed by chest pain in 8 cases (29.6%), fever in 6 cases (22.2%), hemoptysis and sputum in 4 cases (15%), respectively, and dyspnea in 3 cases (11.1%). Other symptoms, including dyspnea on exertion, general weakness, headache, upper abdominal pain and blood tinged sputum, were present in one case, respectively. Respiratory symptoms were present in 22 cases (78.6%) out of 28 cases at the time of diagnosis. Three cases (11.1%) were asymptomatic.

Among those 15 cases in which the hematologic findings could be determined, there was normal finding in 8 cases (53.3%), anemia in 3 cases (20%) and neutropenia, thrombocytopenia, eosinophilia, leukocytosis, elevated ESR in one case, respectively (6.7%). Leukocytosis was observed together with anemia in one case^[@b13-kjim-17-4-252-8])^

Based on the longest diameter, the average size of the lesion was 4.8 cm (1.5--14 cm). As for the location of the lesion in 28 cases, there was lung parenchymal lesion in 24 cases (85.7%), endobronchial lesion in 3 cases (10.7%) and endotracheal lesion in 1 case (3.6%). Other than the endotracheal lesion, the lesion was in the right side in 13 cases (46.4%), in the left side in 12 cases (42.8%) and bilateral in 2 cases (7.1%).

In 27 cases with radiographic or pathologic findings stated, calcification was seen in 5 cases (18.5%)^[@b7-kjim-17-4-252-8],\ [@b8-kjim-17-4-252-8],\ [@b13-kjim-17-4-252-8],\ [@b15-kjim-17-4-252-8],\ [@b16-kjim-17-4-252-8])^ and cavity formation was seen in 3 cases (11.1%)^[@b8-kjim-17-4-252-8],\ [@b14-kjim-17-4-252-8])^.

As for the diagnostic methods, the open thoracotomy was the most prevalent with 23 cases (82.1%) out of 28 cases; among these 23 cases, one case was diagnosed accidentally after the patient underwent left lower lobectomy due to bronchiectasis. Otherwise, the tumor was totally removed using a bronchoscope in 1 case (3.6%)^[@b3-kjim-17-4-252-8])^, and was diagnosed through percutaneous fine needle aspiration (FNA) biopsy in 2 cases (7.1%)^[@b11-kjim-17-4-252-8],\ [@b16-kjim-17-4-252-8])^ and core needle gun biopsy in 2 cases (7.1%)^[@b14-kjim-17-4-252-8])^.

As for treatment, thoracotomy was performed in 23 cases (85.2%) out of 27 cases. Rigid bronchoscopic removal was performed in 1 case (3.7%)^[@b3-kjim-17-4-252-8])^. Prednisolone therapy was done in 2 cases (7.4%) out of 27 cases; in one case, a daily dose of 15 mg was given for 45 days with tapering^[@b11-kjim-17-4-252-8])^. We used 20 mg of prednisolone on the first day and tapered it within the 6 month treatment period. One case (3.7%) showed improvement with the lesion being decreased and symptoms improved with conservative treatment^[@b16-kjim-17-4-252-8])^. Recurrence after surgery was reported in 1 case (4.3%)^[@b6-kjim-17-4-252-8])^ out of 23 cases.

DISCUSSION
==========

As a relatively rare benign disease, the rate of inflammatory pseudotumor located in the lung is 0.7% of all tumors developing in the lung parenchyma and bronchus^[@b17-kjim-17-4-252-8])^ and the rate of tumor development within the bronchus is 6.6% of pulmonary inflammatory pseudotumor^[@b18-kjim-17-4-252-8])^ According to the study by Park et al.^[@b10-kjim-17-4-252-8])^ in 1992, only one case (3.3%) of inflammatory pseudotumor was seen out of 30 cases of benign lung tumors. No gender difference was known to be present and more than a half of the patients were under 40 years of age and 15% of those patients were between the ages of 1--10 years^[@b18-kjim-17-4-252-8],\ [@b19-kjim-17-4-252-8])^ In this study, 81.5% of the cases were male, 55% of them were under 40 years of age, and 1 case was a child under 6 years of age^[@b9-kjim-17-4-252-8])^.

Pulmonary inflammatory pseudotumor is considered as an inflammatory or reactive lesion rather than neoplasm, and about 30% of the patients had a past history of respiratory infection^[@b20-kjim-17-4-252-8],\ [@b21-kjim-17-4-252-8])^. Although the cause of this disease has not been determined accurately, inflammatory lesions are thought to occur locally as a result of excessive response to tissue damages^[@b22-kjim-17-4-252-8])^.

About 60 -- 70% of the patients complained of cough, fever, dyspnea and chest pain^[@b23-kjim-17-4-252-8])^. The results of the present study showed that the symptoms were present in 24 cases (88.9%) out of 27 cases. The asymptomatic 3 cases were incidentally noted by chest X-ray abnormality^[@b14-kjim-17-4-252-8])^.

Laboratory findings were usually within the normal ranges and some could show thrombosytosis, elevated ESR and multiclonal hypergammaglobuminemia^[@b24-kjim-17-4-252-8])^.

Characteristic findings of chest X-ray revealed a solitary, peripheral, sharply circumscribed and lobulated mass^[@b25-kjim-17-4-252-8])^. Those cases with the lesions developed in the bronchus can show obstructive pneumonia or findings of atelectasis, can spread into the lung hilum or mediastinum and rarely accompany pleural effusion^[@b25-kjim-17-4-252-8])^. Calcification is seen with larger lesions^[@b20-kjim-17-4-252-8])^ and lesions are known to form a cavity rarely^[@b25-kjim-17-4-252-8])^. Although calcification was reported in 5 cases in Korea^[@b7-kjim-17-4-252-8],\ [@b8-kjim-17-4-252-8],\ [@b13-kjim-17-4-252-8],\ [@b15-kjim-17-4-252-8],\ [@b16-kjim-17-4-252-8])^, it was not related with the size of the lesion. Cavity formation could be seen in 3 cases^[@b8-kjim-17-4-252-8],\ [@b14-kjim-17-4-252-8])^.

On gross examination of pulmonary inflammatory pseudotumor, a single oval intrapulmonary mass can be demarcated well, it shows golden-brown or red-brown color with no capsule and it is hard in consistency. It can show hemorrhage, necrosis or micro-calcification deposit^[@b19-kjim-17-4-252-8],\ [@b25-kjim-17-4-252-8])^. Histologically, mature plasma cells are the major component of the mass, and fibroblasts, gelatinous substance and, characteristically, the Russel bodies are scattered in palisade or axel form within the hyaline material^[@b19-kjim-17-4-252-8])^. According to histological characteristic, it is distinguished into plasma cell granuloma and histiocytoma. The former form is composed of fibroblast, myofibroblast, collagen and inflammatory cells, and has spindle cells in long and short bundles^[@b20-kjim-17-4-252-8])^. In the latter form, collagen, spindle cells and macrophages are arranged in a whirlpool form and osteodysplasia and calcification can be present^[@b21-kjim-17-4-252-8])^. However, these two are considered to be the same disease since many pathologic findings are repeated and they are clinically very similar^[@b26-kjim-17-4-252-8])^.

Since the findings of inflammation and fibrosis seen in pulmonary inflammatory pseudotumor can be found around the lesion of lung cancer as a reactive response, FNA biopsy may not be an appropriate method of diagnosing inflammatory pseudotumor^[@b21-kjim-17-4-252-8])^. However, the diagnosis of pulmonary inflammatory pseudotumor may be suggested if the combination of a localized density on a chest X-ray and the FNA cytologic findings an taken into account^[@b27-kjim-17-4-252-8])^. Therefore, repeated FNA biopsy can be recommended for diagnosis^[@b28-kjim-17-4-252-8])^. It was reported that a higher accuracy rate can be obtained using core needle gun biopsy compared with FNA biopsy in chest lesions^[@b29-kjim-17-4-252-8])^. Other than pathologic diagnosis after surgery, the diagnosis was made with percutaneous FNA biopsy in 2 cases and with core needle gun biopsy in 2 cases in Korea. However, since the findings of pulmonary inflammatory pseudotumor are non-specific and the disease is not distinguished well from lung cancer or metastatic cancer, the diagnosis of this disease before surgery is rare. Pulmonary inflammatory pseudotumor needs to be distinguished from sclerosing hemangioma, pseudolymphoma and malignant sarcoma^[@b12-kjim-17-4-252-8])^.

Surgery is the treatment of choice in pulmonary inflammatory pseudotumor to distinguish between malignant tumors^[@b18-kjim-17-4-252-8],\ [@b19-kjim-17-4-252-8],\ [@b22-kjim-17-4-252-8],\ [@b23-kjim-17-4-252-8])^. Among 27 cases in which surgery was performed, thoracotomy was performed in 23 cases and removal of the tumor using a bronchoscope was performed in 1 case. Recurrence is reported to be rare^[@b18-kjim-17-4-252-8])^. Only one case of recurrence was reported in Korea from the authors' affiliated hospital^[@b6-kjim-17-4-252-8])^. The inflammatory pseudotumor recurred in the meninges after 10 years and was treated with corticosteroids for 6 years. The follow-up periods were not long and the recurrence might be underestimated even in the world literature because the information from the review of the literature were collected at the time of the report. When lesions were impossible to remove surgically or not removed completely, steroid therapy^[@b11-kjim-17-4-252-8],\ [@b24-kjim-17-4-252-8],\ [@b30-kjim-17-4-252-8])^ or radiation therapy^[@b31-kjim-17-4-252-8])^ were also performed. There was a report that oral prednisolone at the dose of 2 mg/kg/d for 15 weeks reduced the size of lung infiltration^[@b24-kjim-17-4-252-8])^. Oral steroid could be administered in recurred cases after the surgery^[@b30-kjim-17-4-252-8])^. There was a complete disappearance of the mass on chest X-ray with 15 mg/d of prednisolone for 45 days in a Korean report^[@b11-kjim-17-4-252-8])^. We observed the disappearance of the mass on serial chest X-ray and symptomatic improvement with the administration of prednisolone started from 20 mg/d, then tapered for 6 months; no signs of recurrence were seen during the 12 month follow-up. There was a case in which the lesion was decreased and symptoms improved with no specific treatment.

In conclusion, pulmonary inflammatory pseudotumor was more prevalent in the male and patients presenting with the respiratory symptoms were common. It was necessary to do surgery in most cases for the diagnosis and/or treatment.

![52-year-old man with pulmonary inflammatory pseudotumor. The chest radiograph showed a huge mass-like density in the left upper and lower lung fields.](kjim-17-4-252-8f1){#f1-kjim-17-4-252-8}

![The chest CT scan showed a huge mass in the posterior segment of left upper lobe and the superior segment of left lobe. It disclosed the multiple cavitary or cystic lesions and air bronchograms.](kjim-17-4-252-8f2){#f2-kjim-17-4-252-8}

![The chest CT scan showed a huge mass in the posterior segment of left upper lobe and the superior segment of left lobe. It disclosed the multiple cavitary or cystic lesions and air bronchograms.](kjim-17-4-252-8f3){#f3-kjim-17-4-252-8}

![Microscopic findings of the biopsy specimen showed dense lymphoplasmacytic infiltration within fibrotic stroma. (H&E stain, ×40)](kjim-17-4-252-8f4){#f4-kjim-17-4-252-8}

![Microscopic findings of the biopsy specimen showed dense lymphoplasmacytic infiltration within fibrotic stroma. (H&E stain, ×200)](kjim-17-4-252-8f5){#f5-kjim-17-4-252-8}

![Twelve months later, the follow-up chest radiograph with the use of prednisolone revealed a marked-size reduction of the mass.](kjim-17-4-252-8f6){#f6-kjim-17-4-252-8}

###### 

Summary of Features of Pulmonary Inflammatory Pseudotumors in Korea

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Authors                                                         Sex   Age (yr)                               Chief complaint                   Hematologic exam                            Size, location of mass                                                      Cavitation   Calcification         Treatment
  --------------------------------------------------------------- ----- -------------------------------------- --------------------------------- ------------------------------------------- --------------------------------------------------------------------------- ------------ --------------------- ------------------------
  Lee et al^[@b1-kjim-17-4-252-8])^                               M     29                                     dyspnea, chest pain               neutropenia                                 4×2.5 cm, RUL\*\                                                            no           no                    bilobectomy
                                                                                                                                                                                             7×6 cm, RML                                                                                                    

  Kwak et al^[@b2-kjim-17-4-252-8])^                              F     31                                     general weakness, headache        anemia                                      6.5×7.5 cm, LML                                                             no           no                    lobectomy

  Kim et al^[@b3-kjim-17-4-252-8])^                               M     17                                     hemoptysis, dyspnea               not described                               1.5×1.5×1.2 cm, trachea                                                     no           no                    bronchoscopic removal

  Yoo et al^[@b4-kjim-17-4-252-8])^                               M     33                                     dyspnea on exertion, cough        normal                                      1.5 cm, endobronchus of left main                                           no           no                    pneumonectomy

  Chong et al^[@b5-kjim-17-4-252-8])^                             F     44                                     chest pain                        anemia                                      not described, RML and RLL                                                  no           no                    pneumonectomy

  M                                                               30    dry cough                              normal                            diameter 2.5 cm, LLL                        no                                                                          no           lobectomy             

  Lee et al^[@b6-kjim-17-4-252-8])^                               F     24                                     cough, fever                      normal                                      4×4 cm, RLL                                                                 no           no                    lobectomy

  F                                                               46    hemoptysis                             normal                            not described, LUL                          no                                                                          no           lobectomy, recurred   

  Ryoo et al^[@b7-kjim-17-4-252-8])^                              M     17                                     chest discomfort, cough           normal                                      5.5×6.0 cm, RUL                                                             no           yes                   lobectomy

  Kim et al^[@b8-kjim-17-4-252-8])^                               M     55                                     hemoptysis, cough, chest pain     not described                               5×5 cm, RML                                                                 no           yes                   lobectomy

  M                                                               31    fever, chill, chest pain               not described                     5×4 cm, LLL                                 yes                                                                         no           lobectomy             

  M                                                               58    cough, sputum                          not described                     5×7 cm, RUL                                 no                                                                          no           lobectomy             

  Park et al^[@b9-kjim-17-4-252-8])^                              M     6                                      cough, fever                      thrombocytopenia                            not described, RML                                                          no           no                    lobectomy

  Park et al^[@b10-kjim-17-4-252-8])^                             \-    \-                                     bronchiectasis                    not described                               not described, LLL                                                          \-           \-                    lobectomy

  Bang et al^[@b11-kjim-17-4-252-8])^                             M     58                                     sputum                            eosinophilia                                6.0×3.3 cm, 3.0×2.5 cm, LLL, 2.8×2.4 cm, LUL, 3.2×2.5 cm, 1.6×1.2 cm, RLL   no           no                    steroid therapy

  Chae et al^[@b12-kjim-17-4-252-8])^                             M     37                                     fever, chill, cough               not described                               2×1.5×0.5 cm, endobronchus of LLL                                           no           no                    segmentectomy

  Jeon et al^[@b13-kjim-17-4-252-8])^                             M     61                                     dyspnea on exertion, chest pain   leukocytosis, anemia                        not described, left lung                                                    no           yes                   pneumonectomy

  Kim et al^[@b14-kjim-17-4-252-8])^                              M     \-                                     right lower chest pain            not described                               5 cm, RLL                                                                   no           no                    wedge resection

  M                                                               \-    incidentally discovered                not described                     2 cm, RML                                   no                                                                          no           wedge resection       

  M                                                               \-    incidentally discovered                not described                     3 cm, RUL                                   no                                                                          no           wedge resection       

  M                                                               \-    incidentally discovered                not described                     3 cm, RUL                                   no                                                                          no           lobectomy             

  M                                                               \-    intermittent chest pain                not described                     4 cm, LLL                                   no                                                                          no           lobectomy             

  M                                                               \-    blood tinged sputum productive cough   not described                     6 cm, LUL                                   no                                                                          no           lobectomy             

  M                                                               \-    cough, purulent sputum                 not described                     not described, RUL, RLL, and LLL            yes                                                                         no           not described         

  Kim et al^[@b15-kjim-17-4-252-8])^                              M     46                                     right upper quadrant pain         normal                                      5.0×4.0 cm, RUL                                                             no           no                    wedge resection

  F                                                               20    dyspnea, cough, sputum                 normal                            not described, endobronchus of right main   no                                                                          yes          lobectomy             

  Choi et al^[@b16-kjim-17-4-252-8])^                             M     63                                     intermittent fever                elevated ESR                                3 cm, LUL                                                                   no           yes                   spontaneous regression

  Kim et al[^\*\*^](#tfn2-kjim-17-4-252-8){ref-type="table-fn"}   M     52                                     fever, cough, hemoptysis          normal                                      7×7×14 cm, LUL and LLL                                                      yes          no                    steroid therapy
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: RUL, right upper lobe; RML, right middle lobe; RLL, right lower lobe; LLL, left upper lobe; LLL, left lower lobe

Author's case recently experienced in Severance Hospital
